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Peptidoglycan polysaccharide (PG-PS) is a primary structural component of bacterial cell walls and causes
rheumatoid-like arthritis in rats. Recently, glycine has been shown to be a potential immunomodulator;
therefore, the purpose of this study was to determine if glycine would be protective in a PG-PS model of
arthritis in vivo. In rats injected with PG-PS intra-articularly, ankle swelling increased 21% in 24 to 48 h and
recovered in about 2 weeks. Three days prior to reactivation with PG-PS given intravenously (i.v.), rats were
divided into two groups and fed a glycine-containing or nitrogen-balanced control diet. After i.v. PG-PS
treatment joint swelling increased 2.1 6 0.3 mm in controls but only 1.0 6 0.2 mm in rats fed glycine.
Infiltration of inflammatory cells, edema, and synovial hyperplasia in the joint were significantly attenuated by
dietary glycine. Tumor necrosis factor alpha (TNF-a) mRNA was detected in ankle homogenates from rats fed
the control diet but not in ankles from rats fed glycine. Moreover, intracellular calcium was increased signif-
icantly in splenic macrophages treated with PG-PS; however, glycine blunted the increase about 50%. The
inhibitory effect of glycine was reversed by low concentrations of strychnine or chloride-free buffer, and it
increased radiolabeled chloride influx nearly fourfold, an effect also inhibited by strychnine. In isolated splenic
macrophages, glycine blunted translocation of the p65 subunit of NF-kB into the nucleus, superoxide gener-
ation, and TNF-a production caused by PG-PS. Further, mRNA for the beta subunit of the glycine receptor was
detected in splenic macrophages. This work supports the hypothesis that glycine prevents reactive arthritis by
blunting cytokine release from macrophages by increasing chloride influx via a glycine-gated chloride channel.
Peptidoglycan polysaccharide (PG-PS) is a primary struc-
tural component of bacterial cell walls, and injection of PG-PS
induces arthritis in the rat that resembles human rheumatoid
arthritis (29). The mechanism of the pathogenic action of
PG-PS remains largely unclear, but it is thought that inflam-
mation is due, in part, to stimulation of secretion of tumor
necrosis factor alpha (TNF-a), interleukin-1, and other inflam-
matory cytokines as well as oxygen radicals from a variety of
inflammatory cells including macrophages (28, 29). Indeed,
PG-PS is concentrated in macrophages in the spleen, liver, and
mesenteric lymph nodes after systemic injection in rats (28).
Furthermore, PG-PS was detected in the joints of patients with
septic arthritis and rheumatoid arthritis, those PG-PS-contain-
ing cells were mostly macrophages surrounded by T lympho-
cytes. Recently, macrophages were reported to be required in
bacterial and adjuvant-induced arthritis (15). The depletion of
macrophages attenuated the severity of the arthritic lesions in
joints.
NF-kB activation and TNF-a production from macrophages
have been shown to be important in the etiology of rheumatoid
arthritis and bacterial cell wall-induced arthritis (8, 23). Treat-
ment with anti-TNF-a antibody (7) or gene therapy with IkB
superrepressor inhibits the severity of recurrent PG-PS-in-
duced arthritis (23). Anti-TNF-a therapy is the most efficient
new strategy in arthritis treatment from clinical trials, and new
drugs such as soluble TNF receptors represent exciting new
therapies for inflammatory arthritis, especially for patients
who do not respond to methotrexate (39). However, wide-
spread clinical use of these agents has limitations, not the least
of which is expense. Simpler and more economical treatment is
needed.
Glycine is a nonessential amino acid and an inhibitory neu-
rotransmitter in the central nervous system. It can stimulate
glycine-gated chloride channels, leading to increased chloride
influx that hyperpolarizes neuronal membranes and inhibits
excitatory signal transduction (4, 26). Recently, glycine has
been shown to be immunosuppressive in several studies (35,
40). Glycine ameliorates kidney and liver injury during endo-
toxin shock (12), an effect that was due to the blocking of
intracellular calcium signaling and the production of TNF-a
in hepatic Kupffer cells via a glycine-gated chloride channel
(13, 41). Therefore, the purpose of this study was to investigate
whether glycine reduces PG-PS-induced arthritis in vivo and
whether a glycine-gated chloride channel is involved.
(A preliminary account of this work has appeared elsewhere
[18].)
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Arthritis model. Male Lewis rats (175 to 200 g) were injected intra-articularly
with PG-PS (5 mg; Lee Labs, Garrison, Ga.) in one ankle and sterile saline in the
other ankle as a control (30). After 2 weeks, rats were divided randomly into
control and glycine treatment groups; one group was given nitrogen-balanced
AIN-76 diet (20% casein), while the other group received a glycine-containing
diet (15% casein 1 5% glycine; Harlan Teklad, Madison, Wis.). Three days later,
all rats were injected intravenously (i.v.) with 200 mg of PG-PS to reactivate
arthritis.
Joint swelling was evaluated by measurement of ankle diameter, using a digital
caliper by an individual who was blinded to the treatment groups. Each joint was
also evaluated using a limp score based on a scale from 0 to 4: 0, normal gait; 1,
slight alteration of motion; 2, occasional limp; 3, frequent limp but occasional
joint use; 4, withdrawal of paw and no use of joint. One day after the peak of
swelling during the reactivation phase, blood samples were collected for serum
glycine measurements. During the experimental period, body weight and food
consumption were monitored.
Histology analysis. After i.v. injection of PG-PS, ankles were harvested 1 day
after the peak of inflammation. Rats were anesthetized with pentobarbital, and
ankles were amputated, skinned, and fixed in 10% formalin for histological
evaluation. Tissues were stained with hematoxylin and eosin. Histology was
scored from 0 (no damage) to 5 (severe damage) by evaluating panus formation,
inflammatory cell infiltration, synovial lining distension, edema, and bone ero-
sion by a observer blinded to treatment groups (2).
Glycine measurement. Rat serum was collected at the peak of inflammation,
and the glycine concentration was determined. In brief, glycine was extracted
from serum and benzoylated, and the resulting hippuric acid was extracted and
dried by nitrogen (24, 25). The concentration of a colored conjugate of hippuric
acid with dimethylaminobenzaldehyde was determined spectrophotometrically at
458 nm.
Splenic macrophage isolation and culture. Rats were anesthetized, and the
spleen was isolated using aseptic techniques. The spleen was teased apart, rinsed
through mesh with minimal essential medium, (MEM), and centrifuged; then
cells were resuspended in RPMI 1640 containing 10% fetal bovine serum (FBS)
and antibiotics (100 U of penicillin G per ml and 100 mg of streptomycin sulfate
1 per ml). Ten milliliters of 0.15 mM NH4Cl buffer was added to the cell
suspension for 1 min to lyse red cells. Splenocytes were centrifuged (500 3 g), the
pellet was resuspended in medium, cell number was determined using a hemo-
cytometer, and viability was assessed from trypan blue exclusion (.90%). To
purify macrophages, cells were seeded on coverslips or 24-well plates and cul-
tured in RPMI 1640 for 30 min at 37°C in a 5% CO2 atmosphere. Nonadherent
cells were gently removed by replacing media three to five times, and the number
of adherent cells was calculated by difference. Purity of macrophages was above
95% as determined by Wright-Giemsa staining. For all experiments, cells were
incubated in RPMI 1640 24 h before use.
Measurement of intracellular calcium. The intracellular calcium concentra-
tion ([Ca21]i) in splenic macrophages was measured using the fluorescent
[Ca21]i indicator dye fura-2 and a microspectrofluorometer (InCyt Im2 imaging,
Cincinnati, Ohio) interfaced with an inverted microscope (TMS-F; Nikon, To-
kyo, Japan). Splenic macrophages cultured on coverslips were incubated in
modified Hanks’ buffer (115 mM NaCl, 5 mM KCl, 0.3 mM Na2HPO4, 0.4 mM
KH2PO4, 5.6 mM glucose, 0.8 mM MgSO4, 1.26 mM CaCl2, 15 mM HEPES [pH
7.4]) containing 5 mM fura-2-acetoxymethyl ester (Molecular Probes, Eugene,
Oreg.) at room temperature for 30 min. Coverslips with macrophages loaded
with fura-2 were rinsed and placed in chambers with buffer at room temperature.
Changes in fluorescence intensity of fura-2 at excitation wavelengths of 340 and
380 nm and emission at 510 nm were monitored. Each value was corrected by
subtracting the system dark noise and autofluorescence. [Ca21]i was determined
from the equation [Ca21]I 5 Kd[(R 2 Rmin)/(Rmax 2 R)] 3 (F0/Fs). Cells were
selected at random and analyzed using InCyt Im2 image acquisition and analysis
software.
Measurement of chloride uptake. Assays for uptake of chloride were con-
ducted as described previously (32). Briefly, about 5 3 105 cells were incubated
with buffer (20 mM HEPES, 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5
mM CaCl2, 10 mM glucose) for 30 min at room temperature. Coverslips were
gently blotted dry and incubated for 5 s in a petri dish with 2 ml of buffer
containing 2 mCi of 36Cl2 per ml. The coverslips were washed with ice-cold
buffer, which terminated chloride uptake. Radioactivity was detected by liquid
scintillation spectroscopy using a Beckman LC6000SC scintillation counter
(Beckman Instruments Inc., Fullerton, Calif.). Protein was determined by a
Lowry assay (19).
Detection of NF-kB in splenic macrophages. The p65 subunit of NF-kB was
detected in splenic macrophages by a method described previously (14). Isolated
splenic macrophages were incubated for 24 h before the addition of PG-PS (20
mg/ml) in the presence or absence of 1 mM glycine. After 30 min, cells were fixed
with 100% ice-cold methanol for 10 min and blocked with 10% nonimmune goat
serum (NGS; Sigma) for 30 min. Rabbit anti-p65 (Rockland, Gilbertsville, Pa.)
antibody in 10% NGS was added for 30 min, followed by the addition of
rhodamine isothiocyanate-conjugated goat anti-rabbit immunoglobulin G anti-
body in 10% NGS. Nuclear DNA was stained using Hoechst 33258, and p65 and
nuclear DNA were visualized with a fluorescence microscope.
Superoxide release assay. Superoxide production was determined from the
superoxide dismutase-inhibitable reduction of cytochrome c as described else-
where (21). Splenic macrophages (;106 /ml) were seeded onto 24-well plates
with MEM plus 15% FBS, and cytochrome c was added to each well at a final
concentration of 0.8 mg/ml. Cells were incubated with glycine (1 mM) for 3 min
at room temperature before addition of PG-PS. Cells were incubated for 15 min
at 37°C, supernatants were collected, and the reduction of cytochrome c was
measured by spectrophotometry at 550 nm. The differences in absorption be-
tween samples incubated in the presence and absence of superoxide dismutase
(85 U/ml) were compared, and superoxide concentration was calculated using a
millimolar extinction coefficient of 18.5.
RT-PCR. Ankles or splenic macrophages were homogenized, and RNA was
extracted with phenol-chloroform and ethanol precipitation (1). For the synthe-
sis of cDNA, reverse transcription (RT) was performed using murine leukemia
FIG. 1. Effect of dietary glycine on ankle diameter in PG-PS in-
duced arthritis. Arthritis was induced in rats fed control diet by intra-
articular (i.a.) injection of PG-PS (5 mg) into the ankle joint as de-
scribed in Materials and Methods, followed by recovery for 2 weeks.
Three days prior to i.v. injection of PG-PS (200 mg), half of the rats
were switched to 5% glycine diet and control rats received a diet
balanced for nitrogen. Ankle diameter was measured as described in
Materials and Methods. Data are expressed as mean 6 SEM (n 5 5)
(p, P , 0.05; pp, P , 0.01 [one-way ANOVA with Tukey’s post-hoc
test]).
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virus reverse transcriptase. Primers for glycine receptor were designed based on
the cloned sequence of highly conserved regions in the beta subunit of the glycine
receptor from rat spinal cord (41). The forward primer 59-AGGTCATCTTCA
CCCTGAGGAGA-39 and the reverse primer 59-CCAAGTCCAGTGTTGACT
TCAATG-39 generated a 575-bp DNA fragment. Primers for TNF-a were 59-
TACTGAACTTCGGGGTGATTGGTCC-39 and 59-CAGCCTTGTCCCTTGA
AGAGAACC-39, generating a 294-bp DNA fragment. Primers for glyceralde-
hyde-3-phosphate dehydrogenase (G3PDH) were 59-TGAAGGTCGGTGTCA
ACGGATTTG-39 and 59-GTACATCCGTACTCCAGGTGGTG-39 generating
a 982-bp DNA fragment. Primers were prepared at the nucleotide synthesis
facility at the University of North Carolina. Briefly, cDNA was added to a mix-
ture containing 20 mM primer, 2 mM deoxynucleoside triphosphates, polymerase
buffer, and Taq polymerase (1.25 U). The positive controls for G3PDH and
TNF-a were plasmids of PCR fragments from G3PDH and TNF-a cloned into
the subcloning vector pUC19. Amplification products were separated on a 1.5%
agarose gel and visualized by UV illumination.
DNA sequencing. The PCR product generated using glycine receptor primers
from splenic macrophages was subcloned into Escherichia coli, using a TOPO TA
clone kit (Invitrogen, Carlsbad, Calif.). Positive clones with the DNA fragment
were selected and amplified, and DNA was isolated from plasmid (Miniprep
DNA purification system; Promega). Plasmid DNA was sequenced in the facility
of University of North Carolina.
Statistical analysis. All results were expressed as means 6 standard error of
the means (SEM). Statistical differences between groups were determined by
FIG. 2. Histological analysis of ankle joints. Ankles were collected 1 day after the peak of inflammation after PG-PS reactivation as described
in Materials and Methods and stained with hematoxylin and eosin. Typical low-power (12.53; top row) and higher-power (403; bottom row)
photomicrographs are presented. Synovial tissue is marked by arrows, and areas of inflammation are indicated by circles.
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using analysis of variance (ANOVA) with either Tukey’s post-hoc test or Schef-
fe’s post-hoc test where appropriate. Scores were compared by the Mann-Whit-
ney rank sum test. P , 0.05 was selected as the criterion for significance before
initiation of the study.
RESULTS
Body weight and food consumption. During the course of
this study, body weight and food consumption were monitored.
On average, rats grew at the same rate over the course of the
study, with a maximal increase of 40 6 0.5 g in 25 days. Food
consumption increased steadily over the first 18 days of the
experiment. Rats were then randomly divided into two groups;
one group received a glycine-containing diet, and the other
control received a diet for 3 days prior to i.v. injection of
PG-PS. Rats in the two groups studied did not have signifi-
cantly different body weights throughout the experiment. Food
consumption was also not different before reactive arthritis.
After the reinjection of PG-PS, only on day 18, rats given the
control diet consumed 15.6 6 0.5 g of food/day, while rats fed
the glycine diet consumed about 19.4 6 1.2 g/day (P , 0.05).
Effect of glycine on PG-PS-induced arthritis. In this model,
acute arthritis was induced by intra-articlular injection of PG-
PS, while recurrent arthritis was reactivated i.v. After intra-
articular injection of PG-PS, the ankles of PG-PS-treated rats
swelled about 21% in 2 to 3 days (Fig. 1 [representative exper-
iment repeated twice]). The effect subsided substantially 4 days
after PG-PS and was nearly back to baseline in 2 weeks. At that
time, rats were divided into two groups and fed the control or
glycine-containing diet. Three days later, arthritis was reacti-
vated by an i.v. injection of PG-PS. The diameters of ankles of
rats fed the control diet reached a maximal value of 9.2 6 0.2
mm, an increase of 2.1 6 0.3 mm over baseline; however,
FIG. 3. TNF-a mRNA in ankles. Ankle mRNA transcripts were
amplified by RT-PCR from rats fed either control (joint-control) or
glycine (joint-glycine) diet 1 day after reactivation of arthritis using
PG-PS. Ankles were harvested, and RNA was isolated as described in
Materials and Methods. Markers (1.0 kb and 100 bp) and positive
controls specifically for TNF mRNA and G3PDH, the housekeeping
gene, were assayed simultaneously. The data are representative of two
independent experiments.
FIG. 4. Effects of PG-PS and glycine on [Ca21]i and radiolabeled
chloride uptake in cultured splenic macrophages. (A) [Ca21]i was
measured with the fluorescent indicator fura-2 as described in Mate-
rials and Methods in isolated splenic macrophages. Representative
traces from cultured splenic macrophages preincubated in modified
Hanks’ balanced salt solution buffer in the presence or absence of
glycine (1 mM) for 3 min and challenged with PG-PS (10 mg/ml). are
shown. (B) Conditions as in panel A except that the concentration of
glycine was varied. Data are expressed as means 6 SEM (n 5 6 to 10
cells) from three individual experiments. p, P , 0.05 versus no glycine
by one-way ANOVA with Scheffe’s post-hoc test. (C) Glycine (1 mM)
or glycine plus strychnine (Strych; 1 mM) was added for 3 min. in the
presence or absence of chloride-containing buffer (no Cl2) prior to
calcium measurements. Data are mean 6 SEM from five independent
experiments (13 to 28 cells per group). p, P , 0.05 compared to basal;
#, P , 0.05 compared to glycine group by one-way ANOVA. (D) Non
treated splenic macrophages were incubated with 36Cl2 (2 mCi/ml) in
the presence or absence of glycine or glycine plus strychnine (1 mM).
Data are presented as percentage of 36Cl2 uptake in untreated con-
trols from five independent experiments (mean 6 SEM). p, P , 0.05
compared to untreated group; #, P , 0.05 compared to glycine group
by one-way ANOVA on ranks with Tukey’s post-hoc test.
TABLE 1. Effect of glycine on the histological parameters
of PG-PS-induced arthritis
Parameter
Score (mean 6 SEM) (n 5 5/group)
Control diet 5% Glycine diet
Panus formation 2.3 6 0.4 1.2 6 0.4
Inflammatory cell infiltration 3.2 6 0.5 1.4 6 0.4b
Synovial hyperplasia 3.5 6 0.4 2.0 6 0.3b
Edema 3.3 6 0.5 1.5 6 0.4b
Bone erosion 2.8 6 0.5 1.0 6 0.6b
Total score 14.5 6 1.3 7.1 6 1.5b
a Histology was scored in a blinded fashion as described in Materials and
Methods.
b P , 0.05 compared to control joints (Mann-Whitney rank sum test).
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ankles of rats fed the glycine diet had a maximal increase of
only 1.0 6 0.2 mm above baseline (Fig. 1). Thus, feeding
dietary glycine prior to PG-PS reactivation prevented joint
swelling significantly.
Ankle function was also impaired after injection of PG-PS.
After the intra-articular injection of PG-PS, the average limp
score was nearly maximal at 3.5 6 0.4 and decreased to zero by
day 5. After i.v. PG-PS, rats fed the glycine diet had an average
limp score of 1.2 6 0.7, significantly lower than that of the
control group (3.6 6 0.4).
Serum was collected immediately after the peak of ankle
swelling on day 22. In the control group, the serum glycine
concentration was 0.18 6 0.15 mM. In rats fed glycine, the
glycine concentration was 0.95 6 0.10 mM, similar to values
shown to be protective in a model of endotoxin shock (12).
Inflammation due to PG-PS. One day after the peak of joint
swelling, severe infiltration of inflammatory cells and swelling
both in the synovium and surrounding tissue were observed in
rats fed the control diet (Fig. 2). Neovascularization with oc-
casional areas of hemorrhage and a few lymphocytic foci,
chiefly in the synovium, were observed in PG-PS-treated con-
trol rats. Synovial cell hyperplasia was significant, with an in-
crease in the number and size of synovial cells in the tibiotarsal
joint and in the bursa of the Achilles tendon. In rats fed the
glycine-containing diet, only a slight increase in the number
and size of synovial cells was observed. Several parameters of
histological changes are summarized in Table 1. Synovial hy-
pertrophy, increases in inflammatory cells, and edema were the
main pathological changes detected in the joints from control
rats. Dietary glycine significantly attenuated the synovial ex-
tension, edema, and inflammatory infiltration to different ex-
tents. There was moderate cartilage destruction in control an-
kles, while bone destruction was less extensive in joints of rats
in the glycine group (Table 1). Thus, consistent with the joint
swelling (Fig. 1), glycine blunted pathological changes in the
joint caused by PG-PS by about 50%.
One day after the peak of reactivation of arthritis by i.v.
injection of PG-PS, ankles were harvested and homogenized
and RNA was isolated. mRNA for TNF-a was detected in
ankles from rats fed the control diet (Fig. 3) but not in ankles
from rats fed the glycine-containing diet.
Additionally, isolated splenic macrophages (0.8 3 106) were
incubated with or without glycine (1 mM) for 1 h. The addition
of glycine lowered the increase in TNF-a caused by PG-PS (50
mg/ml) from 1,014 6 60 pg/ml to 717 6 86 pg/ml (P , 0.05). In
the absence of PG-PS, TNF-a levels were below detection
limits.
Effect of PG-PS on intracellular calcium in splenic macro-
phages. Since rat joints are small, technical difficulties were
encountered in obtaining an adequate number of synovial mac-
rophages. Therefore, we used splenic macrophages as a model
to study the effect of glycine in intracellular signaling. [Ca21]i
was monitored after the addition of PG-PS (10 mg/ml) plus 5%
rat serum to splenic macrophages. Without addition of rat
serum, PG-PS did not increase calcium; however, with serum,
PG-PS quickly increased [Ca21]i about 17-fold over basal val-
ues in about 1 min; the level returned to baseline in 4 to 6 min
(Fig. 4A). In contrast, after 3 min of preincubation with 1 mM
glycine, the increase in [Ca21]i was slow and peaked at a level
much lower than in control cells. On average, PG-PS increased
[Ca21]i in splenic macrophages to 122 6 8 nM. The maximal
increase was blunted about 50% by 1 mM glycine (Fig. 4C).
Furthermore, the inhibitory effect of glycine was dose depen-
dent (Fig. 4B; half-maximal effect 5 0.55 mM glycine).
To determine if the effect of glycine occurred through a
glycine-gated chloride channel, the specific glycine receptor
antagonist strychnine was studied. Preincubation of strychnine
(1 mM) with glycine reversed the inhibitory effect of glycine
completely (Fig. 4C). Chloride-free buffer also reversed the
inhibitory effect of glycine significantly.
Glycine increases chloride influx. Hyperpolarization of the
plasma membrane due to influx of chloride is the mechanism
of the inhibitory effect of glycine in the central nervous system
and in a variety of white blood cells (40). To investigate wheth-
er glycine affects chloride influx in splenic macrophages, radio-
labeled chloride influx was measured. Indeed, glycine increased
chloride uptake by splenic macrophages about fourfold (Fig.
4D). This increase of chloride influx by glycine was reduced
significantly by strychnine.
Molecular evidence for a glycine receptor in splenic macro-
phages. Figure 5 demonstrates the detection of mRNA of the
beta subunit of the glycine receptor in splenic macrophages.
The 575-bp fragment from splenic macrophages was identical
to the positive control from the spinal cord, consistent with the
finding that splenic macrophages contain a beta subunit similar
to the 58-kDa subunit in the spinal cord. Furthermore, the
PCR product from splenic macrophages was sequenced and
found to have 98% homology with a cDNA segment of the
beta subunit of the glycine receptor (GenBank accession no.
X81202). This is the first study to provide molecular evidence
demonstrating the presence of a glycine-gated chloride chan-
nel in splenic macrophages.
Detection of NF-kB in splenic macrophages. The pivotal
transcription factor NF-kB is important for the production of
TNF-a. In untreated splenic macrophages, the p65 subunit of
NF-kB was detected in cytoplasm, indicating that it was in an
inactive form (Fig. 6, top row). PG-PS stimulated the translo-
cation of p65 into the nucleus in about 60% of the cells (Fig. 6,
middle row). In contrast, glycine (1 mM) blocked the nuclear
translocation of p65 by PG-PS nearly completely (Fig. 6, bot-
tom row).
FIG. 5. Glycine receptor mRNA in splenic macrophages. Total
RNA was isolated from splenic macrophages as described in Materials
and Methods. The glycine receptor was identified by RT-PCR using
primers specific for conserved regions in the beta subunit, (GlyRb).
The negative control was total RNA from splenic macrophages with-
out RT. The PCR product was confirmed by sequencing as described
in Materials and Methods. The data are representative of three inde-
pendent experiments. Sizes are indicated in base pairs.
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Superoxide generation by splenic macrophages is inhibited
by glycine. Phagocytes express NADPH oxidase in the cell
membrane; therefore, the effect of PG-PS on superoxide pro-
duction by splenic macrophages was evaluated (Fig. 7). In the
absence of PG-PS, cells generated superoxide at rates of 1.9 6
0.5 nmol 106 cells/15 min. PG-PS (10 mg/ml) increased values
to 8.5 6 1.4 nmol/106 cells/15 min. Interestingly, the increase in
superoxide release due to PG-PS was reduced significantly
(about 45%) by glycine.
DISCUSSION
Glycine inhibits PG-PS-induced arthritis. The PG-PS-in-
duced arthritis model has been used widely in studies of the
etiology of rheumatoid arthritis because it mimics the clinical
patterns observed in arthritic patients (3). One intra-articular
dose of PG-PS causes a synovitis that reverts in a few days.
Reactivation after a small i.v. dose of PG-PS causes a more
severe, chronic, cyclic inflammation which is produced in the
injured joint and eventually causes permanent destruction
(31). This cell wall complex is resistant to breakdown in the
body and remains in the tissue for long periods of time (3).
PG-PS is retained in the joints and synovial fluid of some
rheumatoid arthritis patients (16, 22, 37). Interestingly, over-
growth of small bowel bacteria induces reactivation of arthritis
possibly due to PG-PS; however, the mechanism of the patho-
genic actions of PG-PS is still unclear (11, 29, 34). PG-PS might
induce a variety of persistent inflammatory diseases (i.e., car-
ditis, granulomatus hepatitis, and enterocolitis) by production
of cytokines and oxygen radicals (29). Here, PG-PS-induced
both acute and reactive inflammation in PG-PS-injected an-
kles, as expected (Fig. 1), and elevated TNF-a mRNA in swol-
len ankles (Fig. 3).
Dietary glycine increases blood glycine levels four- to five-
fold to levels which are protective in endotoxin shock and
which prevent experimental liver tumors (12, 27). In vivo, gly-
cine significantly blunted joint swelling (Fig. 1) and reduced
the limp score of rats during reactive arthritis. Additionally,
TNF-a mRNA (Fig. 3) could not be detected in ankles from
rats fed glycine, and glycine reduced TNF-a production by
macrophages about 30% in vitro (Results). Therefore, it is
hypothesized that dietary glycine inhibits ankle inflammation
by blunting TNF-a production.
FIG. 6. Effects of PG-PS and glycine on nuclear translocation of the p65 subunit of NF-kB. Splenic macrophages were stimulated with PG-PS
(20 mg/ml) in the presence or absence of glycine (1 mM). The p65 subunit in cells was detected with an anti-p65 antibody as described in Materials
and Methods. Nuclear DNA was stained using Hoechst 33342, and the p65 subunit and nuclear DNA were visualized with a fluorescence
microscope. The data are representative of three independent experiments. Top row, untreated cells; middle row, cells treated with PG-PS (20
mg/ml) plus 5% rat serum; bottom row, glycine-pretreated cells treated with PG-PS.
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Anti-inflammatory effect of glycine and role of the glycine
receptor. The mechanism of PG-PS activation of macrophages
is not completely understood. It is suggested that PG-PS shares
a similar signaling pathway with lipopolysaccharide (LPS) by
activating CD14 (6, 10). Recent work has demonstrated that
knockout mice which lack the Toll-like receptor 4 (TLR4) do
not respond to LPS but do respond to PG-PS; however, mice
without TLR2 respond similarly to wild-type mice after LPS
but not PG-PS (36). Moreover, TLR2 receptors are responsive
to gram-positive bacteria (i.e., to PG-PS) and activity of TLR2
is potentiated by CD14 (42). These studies support the hypoth-
esis that TLR2 and CD14 are involved in signaling due to
PG-PS.
It is well known that intracellular calcium signals are impor-
tant for activation and release of cytokines from inflammatory
cells (5, 38). Voltage-dependent calcium channels are opened
based on the membrane potential of the cell membrane (17).
Signal transduction leads to depolarization of the plasma
membrane, causing calcium influx. Like LPS, PG-PS increases
intracellular calcium in splenic macrophages, an effect depen-
dent on serum binding proteins (Fig. 4).
In phagocytes, one mechanism for superoxide generation is
via NADPH oxidase, which is regulated, directly or indirectly,
by calcium signaling. For example, increases in intracellular
calcium activates protein kinase C, resulting in an increase in
NADPH oxidase which leads to the production of oxidants,
activation of NF-kB, and stimulation of TNF-a production
(33). PG-PS was reported to activate NF-kB and increase the
production of TNF-a (9, 10). In this study, translocation of the
p65 subunit of NF-kB into the nucleus and production of
TNF-a both in vitro and in vivo were also observed (Fig. 3 and
Results). Interestingly, glycine blunts the elevation of intracel-
lular calcium after PG-PS in a dose-dependent manner (Fig.
4B), inhibits superoxide production (Fig. 7), and blunts both
nuclear translocation of NF-kB (Fig. 6) and TNF-a production
(Results). Differences in amplitude and duration of intracellu-
lar calcium signals activate a variety of transcription factors.
For example, the amplitude of the calcium signal has been
reported to be critical for NF-kB activation (5). Changes in the
intracellular calcium signal patterns in macrophages by glycine
(Fig. 4) may explain the beneficial effect of glycine in PG-PS-
induced arthritis. Moreover, the results suggest that intracel-
lular calcium plays an important role in the intracellular sig-
naling of PG-PS.
Glycine has long been known to be an inhibitory neurotrans-
mitter in the spinal cord (4) and acts by binding to receptors
which are localized largely in postsynaptic neuronal mem-
branes. Glycine receptors in the neuron are comprised of three
distinct protein subunits: a 48-kDa alpha subunit, a 58-kDa
beta subunit, and a cytoplasmic anchoring protein, gephyrin.
Glycine triggers the opening of this chloride channel, leading
to influx of chloride that hyperpolarizes the cell membrane in
opposition to the depolarizing action of excitatory signals. In
FIG. 7. Effect of glycine on superoxide production. Splenic macro-
phages were incubated in MEM with 15% FBS, HEPES, and antibi-
otics, and superoxide production was measured as described in Mate-
rials and Methods. Briefly, glycine (1 mM) was added to cells 3 min
before the addition of PG-PS (10 mg/ml). Data are the means 6 SEM
from four independent experiments. p, P , 0.05 by one-way ANOVA
with Tukey’s post-hoc test compared with control group; #, P , 0.05
by one-way ANOVA with Tukey’s post-hoc test compared with PG-PS
alone.
FIG. 8. Working hypothesis for the mechanism of action of glycine
in PG-PS-induced arthritis in the rat. PG-PS from gram-positive bac-
teria plays an important role in the etiology of arthritis. It is proposed
that PG-PS stimulates CD14 and TLR2, resulting in increases in in-
tracellular calcium. This stimulates NADPH oxidase and generates
superoxide, which activates NF-kB, leading to TNF-a production. Gly-
cine (GLY) blunts PG-PS-induced increases in [Ca21]i, an effect re-
versed by low concentrations of strychnine or depletion of chloride.
The inhibition of superoxide production and TNF-a generation by
glycine is most likely due to blunting of the intracellular calcium
signaling pathway. These data are consistent with the hypothesis that
glycine activates a glycine receptor, leading to influx of chloride which
hyperpolarizes the macrophage membrane and decreases the opening
time of voltage-dependent calcium channels. In vivo treatment with
glycine blocks PG-PS-induced arthritis most likely via a similar mech-
anism.
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splenic macrophages, the inhibitory effect of glycine is blocked
by the high-affinity specific glycine receptor against strychnine
and is dependent on extracellular chloride (Fig. 4C and D).
Recently, evidence for a glycine-gated chloride channel has
also been obtained for other macrophages, such as Kupffer
cells (40). Here, the beta subunit of the glycine-gated chloride
channel, which was 98% identical to the cDNA segment of the
mouse glycine receptor from the GenBank database, was de-
tected in splenic macrophages (Fig. 5). Similarly, glycine in-
creased the influx of radiolabeled chloride into cells (Fig. 4D).
Thus, the glycine receptor of splenic macrophages is nearly
identical to glycine receptors described elsewhere (40). This
finding supports the hypothesis that glycine has direct effects
on inflammatory cells.
Based on the data presented in this study, the following
mechanism is proposed to explain these findings (Fig. 8). PG-
PS activates CD14 and TLR2, which stimulates phospholipase
C and increases intracellular calcium, a critical signal in the
inflammatory response. This causes assembly of NADPH oxi-
dase, most likely via protein kinase C, leading to superoxide
production, which causes translocation of NF-kB, resulting in
TNFa production. Glycine blunts PG-PS-induced increases in
[Ca21]i, an effect reversed by low concentrations of strychnine
and depletion of extracellular chloride (Fig. 4C and D). Inhi-
bition of superoxide production and TNF-a generation by gly-
cine is most likely due to the blunting of calcium signals. These
data are consistent with the hypothesis that glycine activates a
glycine receptor (Fig. 5), leading to the influx of chloride which
hyperpolarizes the macrophage membrane and decreases the
opening time of voltage-dependent calcium channels. In vivo
treatment with glycine blocks PG-PS-induced arthritis likely
via this mechanism.
Clinical significance. In clinical trials, therapy against TNF-
a with soluble anti-TNF-a receptor or anti-TNF-a antibody
reduced the severity of rheumatoid arthritis (20). Soluble TNF
receptors which neutralize TNF-a before joints are damaged
has become a new exciting strategy for therapy (39). Combi-
nation therapy of these drugs with methotrexate appears par-
ticularly effective in patients whose disease persists despite
traditional drug therapy. However, these therapies are limited
due to expense or adverse side effects. Glycine, a dietary nu-
trient, is anti-inflammatory and has protective effects in exper-
imental arthritis by reducing TNF-a production (Fig. 3). Since
dietary glycine is easily administered, inexpensive, and non-
toxic, it could supplement current therapies for arthritis.
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